Ichthammol
US-FDASourced from openFDA
GET
/api/v1/drug/ichthammolIndications
Sourced from openFDA- Suggested Use • Treating insect bites and stings from mosquitoes, spider, and bees • Removing splinters and silvers • Treating plant irritations, such as nettles or poison ivy • Treating minor skin infections such as an ingrown toenail • Soothing skin relief • Apply to minor skin irritations
Dosage & administration
Sourced from openFDADirections Cleanse affected area. Apply on gauze bandage once or twice a day. Repeat as necessary. Do not rub or massage affected area.
Warnings & precautions
Sourced from openFDA• For external use only • Do not use in eyes • Ask a doctor before use if you have deep puncture wounds or serious burns •
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
529 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Pain366.8%
- 2Diarrhoea336.2%
- 3Headache336.2%
- 4Nausea326.0%
- 5Fatigue315.9%
- 6Drug Ineffective285.3%
- 7Dizziness275.1%
- 8Arthralgia264.9%
- 9Pain In Extremity214.0%
- 10Asthenia193.6%
- 11Malaise193.6%
- 12Insomnia183.4%
- 13Abdominal Pain Upper173.2%
- 14Constipation173.2%
- 15Eye Pain173.2%
Clinical trials
The 10 most recently updated of 154 ClinicalTrials.gov registrations naming Ichthammol as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)Recruiting · Phase 2 · Interventional · 461 enrolled · National Cancer Institute (NCI)NCT04546399updated 2026-06-12
- Dexamethasone in Controlling Dyspnea in Patients With CancerActive not recruiting · Phase 2 · Interventional · 135 enrolled · M.D. Anderson Cancer CenterNCT03367156updated 2026-06-11
- Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain AmyloidosisActive not recruiting · Phase 1 · Interventional · 24 enrolled · National Cancer Institute (NCI)NCT04847453updated 2026-06-11
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple MyelomaActive not recruiting · Phase 3 · Interventional · 525 enrolled · National Cancer Institute (NCI)NCT00644228updated 2026-06-11
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruiting · Phase 2 · Interventional · 153 enrolled · National Cancer Institute (NCI)NCT06317662updated 2026-06-11
- Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentRecruiting · Phase 3 · Interventional · 510 enrolled · SWOG Cancer Research NetworkNCT05561387updated 2026-06-10
- Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More TreatmentNot yet recruiting · Phase 2 · Interventional · 90 enrolled · SWOG Cancer Research NetworkNCT07636564updated 2026-06-09
- CRUISE System in FlightNot yet recruiting · Observational · 60 enrolled · Hernando GomezNCT07637240updated 2026-06-09
- Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaActive not recruiting · Phase 3 · Interventional · 847 enrolled · National Cancer Institute (NCI)NCT02112916updated 2026-06-03
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaActive not recruiting · Phase 3 · Interventional · 669 enrolled · National Cancer Institute (NCI)NCT02101853updated 2026-06-03
Frequently asked questions
- What is Ichthammol used for?
- According to FDA labeling, Ichthammol carries indications including: Suggested Use • Treating insect bites and stings from mosquitoes, spider, and bees • Removing splinters and silvers • Treating plant irritations, such as nettles or poison ivy • Treating minor skin infections such as an ingrown toenail • Soothing skin relief • Apply to minor skin irritations. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
ichthammol is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.